FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii
Introduction: Metastatic malignant struma ovarii (MSO) is an extremely rare disease that lacks treatment consensus and accurate prognosis. The objective of this study was to present the clinical, pathological, and treatment characteristics of metastatic MSO, while also investigate the overall surviv...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
Frontiers Media S.A.
2020-09-01
|
| Serija: | Frontiers in Oncology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/article/10.3389/fonc.2020.584917/full |